Glenmark Pharma stock slips 2%; Delhi HC restrains from selling anti-diabetes drugs
Report says that Delhi High Court restrained Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed the patent of the American company.